KDR and hepatocellular carcinoma: Additionally, it has been reported to work in conjunction with vascular endothelial growth factor receptors (VEGFR)‐2 and VEGFR‐3, influencing hepatic vascular development and potentially contributing to HCC onset in patients with chronic hepatitis C [25].